Trial intelligence / Profile preview

Doxycycline versus placebo for established knee osteoarthritis

NL-OMON31361Phase 3Not yet recruiting

Sponsor
Sint Maartenskliniek
Start
Jul 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in knee osteoarthritis (OA) comparing Doxycycline with Placebo (2 arms). Primary endpoint: OMERACT-OARSI clinical response at week 24. Planned start Jul 2007; status: not yet recruiting.

02

Drugs

doxycycline
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NL-OMON31361.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON31361.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call